(Q34779943)

English

Pyrimidine-2,4,6-trione derivatives and their inhibition of mutant SOD1-dependent protein aggregation. Toward a treatment for amyotrophic lateral sclerosis

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

4 August 2017

Pyrimidine-2,4,6-trione derivatives and their inhibition of mutant SOD1-dependent protein aggregation. Toward a treatment for amyotrophic lateral sclerosis (English)

1 reference

Europe PubMed Central

4 August 2017

amyotrophic lateral sclerosis

0 references

protein aggregation

1 reference

based on heuristic

inferred from title

Robert J Ferrante

6

object named as

Robert J Ferrante

1 reference

Europe PubMed Central

4 August 2017

author name string

Guoyao Xia

1

1 reference

Europe PubMed Central

4 August 2017

Radhia Benmohamed

2

1 reference

Europe PubMed Central

4 August 2017

Jinho Kim

3

1 reference

Europe PubMed Central

4 August 2017

Anthony C Arvanites

4

1 reference

Europe PubMed Central

4 August 2017

Richard I Morimoto

5

1 reference

Europe PubMed Central

4 August 2017

Donald R Kirsch

7

1 reference

Europe PubMed Central

4 August 2017

Richard B Silverman

8

1 reference

Europe PubMed Central

4 August 2017

language of work or name

0 references

publication date

4 March 2011

1 reference

Europe PubMed Central

4 August 2017

Journal of Medicinal Chemistry

1 reference

Europe PubMed Central

4 August 2017

54

1 reference

Europe PubMed Central

4 August 2017

2409-2421

1 reference

Europe PubMed Central

4 August 2017

7

1 reference

Europe PubMed Central

4 August 2017

Identification of compounds protective against G93A-SOD1 toxicity for the treatment of amyotrophic lateral sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3074252

7 July 2018

Non-cell autonomous toxicity in neurodegenerative disorders: ALS and beyond

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3074252

7 July 2018

The interactions between hERG potassium channel and blockers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3074252

7 July 2018

Blockade of the I(Ks) potassium channel: an overlooked cardiovascular liability in drug safety screening?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3074252

7 July 2018

Current hypotheses for the underlying biology of amyotrophic lateral sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3074252

7 July 2018

Proteotoxic stress and inducible chaperone networks in neurodegenerative disease and aging

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3074252

7 July 2018

hERG potassium channels and the structural basis of drug-induced arrhythmias

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3074252

7 July 2018

Interrupting apoptosis in neurodegenerative disease: potential for effective therapy?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3074252

7 July 2018

The epidemiology of motor neuron diseases: a review of recent studies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3074252

7 July 2018

Evaluation and rehabilitation of patients with adult motor neuron disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3074252

7 July 2018

ALS-linked SOD1 mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3074252

7 July 2018

Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3074252

7 July 2018

Palliative care for patients with amyotrophic lateral sclerosis: "prepare for the worst and hope for the best".

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3074252

26 October 2018

A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS/Riluzole Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/21375347

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Riluzole series. Synthesis and in vivo "antiglutamate" activity of 6-substituted-2-benzothiazolamines and 3-substituted-2-imino-benzothiazolines

1 reference

https://pubmed.ncbi.nlm.nih.gov/21375347

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1021/JM101549K

1 reference

Europe PubMed Central

4 August 2017

1 reference

Europe PubMed Central

4 August 2017

1 reference

Europe PubMed Central

4 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34779943&oldid=1962850262"